Inmed Pharmaceuticals Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Inmed Pharmaceuticals Inc  (NASDAQ: INM)

INM's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2026)
2026
(Jun 30 2025)
2025
(Mar 31 2024)
2024
(Jun 30 2023)
2023
(Jun 30 2022)
2022
Y / Y Equity Change -92 % 20.98 % -8.15 % 33.17 % 23.07 %
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Inmed Pharmaceuticals Inc's Equity $ 1 Millions Annual INM's Balance sheet
Inmed Pharmaceuticals Inc's Annual Income $ -13 Millions Annual INM's Income Statement
Where are INM's Income coming from? Visit INM's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.